JP2015528463A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015528463A5 JP2015528463A5 JP2015529881A JP2015529881A JP2015528463A5 JP 2015528463 A5 JP2015528463 A5 JP 2015528463A5 JP 2015529881 A JP2015529881 A JP 2015529881A JP 2015529881 A JP2015529881 A JP 2015529881A JP 2015528463 A5 JP2015528463 A5 JP 2015528463A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- compound according
- hydroxyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261693437P | 2012-08-27 | 2012-08-27 | |
| US61/693,437 | 2012-08-27 | ||
| PCT/US2013/056418 WO2014035827A1 (en) | 2012-08-27 | 2013-08-23 | Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015528463A JP2015528463A (ja) | 2015-09-28 |
| JP2015528463A5 true JP2015528463A5 (https=) | 2016-10-13 |
| JP6270848B2 JP6270848B2 (ja) | 2018-01-31 |
Family
ID=49117974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015529881A Expired - Fee Related JP6270848B2 (ja) | 2012-08-27 | 2013-08-23 | ベータ−クロロシクロペンタンの親水性エステルプロドラッグの使用による角膜中央部肥厚の低下 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9024042B2 (https=) |
| EP (1) | EP2888239B1 (https=) |
| JP (1) | JP6270848B2 (https=) |
| KR (2) | KR102304111B1 (https=) |
| CN (1) | CN104684904B (https=) |
| AU (1) | AU2013309124B2 (https=) |
| CA (1) | CA2882743C (https=) |
| DK (1) | DK2888239T3 (https=) |
| ES (1) | ES2711425T3 (https=) |
| TR (1) | TR201900863T4 (https=) |
| WO (1) | WO2014035827A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201900863T4 (tr) | 2012-08-27 | 2019-02-21 | Allergan Inc | Beta-klorosiklopentanların hidrofilik ester ön ilaçlarının kullanılmasıyla merkezi korneal kalınlaşmanın azaltılması. |
| TR201902864T4 (tr) * | 2014-02-20 | 2019-03-21 | Allergan Inc | Beta-klorosiklopentanların hidrofilik ester ön ilaçlarının kullanımı ile azaltılmış merkezi korneal kalınlaşma. |
| US9981938B2 (en) | 2014-05-12 | 2018-05-29 | Allergan, Inc. | Quaternary ammonium alkyl esters as stable prodrugs |
| WO2015179815A1 (en) * | 2014-05-22 | 2015-11-26 | Allergan, Inc. | Amidoalkylenyl and amidoaryl esters, compositions thereof, and methods for their use |
| CA2962766A1 (en) * | 2014-10-02 | 2016-04-07 | Allergan, Inc. | Ester prodrugs of gamma-lactams and their use |
| BR102018007822A2 (pt) | 2017-04-20 | 2018-11-06 | Gilead Sciences, Inc. | composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição |
| TWI707849B (zh) | 2018-02-13 | 2020-10-21 | 美商基利科學股份有限公司 | Pd‐1/pd‐l1抑制劑 |
| KR102591947B1 (ko) | 2018-04-19 | 2023-10-25 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
| EP3820572B1 (en) | 2018-07-13 | 2023-08-16 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| US11236085B2 (en) | 2018-10-24 | 2022-02-01 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| ATE141502T1 (de) | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US6353000B1 (en) | 1996-11-12 | 2002-03-05 | Alcon Laboratories, Inc. | 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension |
| DE10322843A1 (de) | 2003-05-19 | 2004-12-16 | Clariant Gmbh | Verfahren zur Herstellung von Anilinboronsäuren und ihren Derivaten |
| WO2006047466A2 (en) | 2004-10-21 | 2006-05-04 | Duke University | Ophthamological drugs |
| US7091231B2 (en) * | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
| US20070254920A1 (en) | 2006-04-26 | 2007-11-01 | Aerie Pharmaceuticals, Inc. | Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
| JP5570807B2 (ja) * | 2006-07-11 | 2014-08-13 | アラーガン インコーポレイテッド | 抗緑内障薬としてのシクロペンタン誘導体 |
| US7947732B2 (en) * | 2007-07-13 | 2011-05-24 | Allergan, Inc. | Therapeutic substituted chlorocyclopentanols |
| US7732443B2 (en) * | 2008-03-18 | 2010-06-08 | Yariv Donde | Therapeutic substituted cyclopentanes |
| US7737140B2 (en) | 2008-04-24 | 2010-06-15 | Allergan, Inc. | Therapeutic compounds |
| US8592413B2 (en) * | 2008-05-15 | 2013-11-26 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
| PH12012500928A1 (en) | 2009-11-09 | 2012-11-26 | Allergan Inc | Compositions and methods for stimulating hair growth |
| US20110136872A1 (en) | 2009-12-09 | 2011-06-09 | Burk Robert M | Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| US9090595B2 (en) | 2012-08-27 | 2015-07-28 | Allergan, Inc. | Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes |
| TR201900863T4 (tr) | 2012-08-27 | 2019-02-21 | Allergan Inc | Beta-klorosiklopentanların hidrofilik ester ön ilaçlarının kullanılmasıyla merkezi korneal kalınlaşmanın azaltılması. |
-
2013
- 2013-08-23 TR TR2019/00863T patent/TR201900863T4/tr unknown
- 2013-08-23 DK DK13759081.6T patent/DK2888239T3/en active
- 2013-08-23 KR KR1020157007444A patent/KR102304111B1/ko not_active Expired - Fee Related
- 2013-08-23 JP JP2015529881A patent/JP6270848B2/ja not_active Expired - Fee Related
- 2013-08-23 US US13/974,975 patent/US9024042B2/en active Active
- 2013-08-23 CA CA2882743A patent/CA2882743C/en active Active
- 2013-08-23 CN CN201380051147.7A patent/CN104684904B/zh not_active Expired - Fee Related
- 2013-08-23 ES ES13759081T patent/ES2711425T3/es active Active
- 2013-08-23 AU AU2013309124A patent/AU2013309124B2/en not_active Ceased
- 2013-08-23 KR KR1020207026858A patent/KR20200110820A/ko not_active Ceased
- 2013-08-23 EP EP13759081.6A patent/EP2888239B1/en active Active
- 2013-08-23 WO PCT/US2013/056418 patent/WO2014035827A1/en not_active Ceased
-
2015
- 2015-04-13 US US14/685,414 patent/US9427401B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015528463A5 (https=) | ||
| JP2017537940A5 (https=) | ||
| JP2013510123A5 (https=) | ||
| JP2014511891A5 (https=) | ||
| JP2017526726A5 (https=) | ||
| JP2019524883A5 (https=) | ||
| JP2014531434A5 (https=) | ||
| CY1119727T1 (el) | Ενωσεις και συνθεσεις για τη θεραπεια παρασιτικων νοσων | |
| JP2011219498A5 (https=) | ||
| JP2014511892A5 (https=) | ||
| JP2015508092A5 (https=) | ||
| RU2018128318A (ru) | Селективные ингибиторы эстрогеновых рецепторов и их применение | |
| JP2015522650A5 (https=) | ||
| JP2015528002A5 (https=) | ||
| JP2007504235A5 (https=) | ||
| JP2016526574A5 (https=) | ||
| JP2015512413A5 (https=) | ||
| JP2011137045A5 (https=) | ||
| JP2017523152A5 (https=) | ||
| JP2019535723A5 (https=) | ||
| JP2014526533A5 (https=) | ||
| RU2011102396A (ru) | Аминосоединения и их медицинское применение | |
| JP2016529235A5 (https=) | ||
| JP2020511450A5 (https=) | ||
| JP2017522304A5 (https=) |